JP2008513500A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008513500A5 JP2008513500A5 JP2007532632A JP2007532632A JP2008513500A5 JP 2008513500 A5 JP2008513500 A5 JP 2008513500A5 JP 2007532632 A JP2007532632 A JP 2007532632A JP 2007532632 A JP2007532632 A JP 2007532632A JP 2008513500 A5 JP2008513500 A5 JP 2008513500A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- group
- alkyl
- substituted
- piperidinyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 101
- 125000001424 substituent group Chemical group 0.000 claims 86
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 80
- 125000001072 heteroaryl group Chemical group 0.000 claims 79
- 229910003827 NRaRb Inorganic materials 0.000 claims 52
- 125000005843 halogen group Chemical group 0.000 claims 51
- -1 -ORc Chemical group 0.000 claims 36
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 34
- 125000000753 cycloalkyl group Chemical group 0.000 claims 34
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 28
- 125000004043 oxo group Chemical group O=* 0.000 claims 21
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 18
- 150000001875 compounds Chemical class 0.000 claims 17
- 125000000217 alkyl group Chemical group 0.000 claims 16
- 125000003118 aryl group Chemical group 0.000 claims 13
- 150000003839 salts Chemical class 0.000 claims 13
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 12
- 125000004093 cyano group Chemical group *C#N 0.000 claims 9
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 8
- 125000001188 haloalkyl group Chemical group 0.000 claims 8
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 6
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 5
- 150000001408 amides Chemical class 0.000 claims 5
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims 5
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 claims 4
- 125000004429 atom Chemical group 0.000 claims 4
- 238000006467 substitution reaction Methods 0.000 claims 4
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 3
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 3
- 125000005842 heteroatom Chemical group 0.000 claims 3
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 2
- CAVRRSRWRKKJPD-UHFFFAOYSA-N 3-[1-(2-methoxyethylsulfonyl)piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 CAVRRSRWRKKJPD-UHFFFAOYSA-N 0.000 claims 2
- PQPZVWJPKZMXJV-UHFFFAOYSA-N 3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 PQPZVWJPKZMXJV-UHFFFAOYSA-N 0.000 claims 2
- KBLLMOCRHWALMG-UHFFFAOYSA-N 3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-5-thiophen-3-yl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C3=CSC=C3)C=C12 KBLLMOCRHWALMG-UHFFFAOYSA-N 0.000 claims 2
- JXUXTVXXOBFIHD-UHFFFAOYSA-N 3-[1-(3-morpholin-4-ylpropylsulfonyl)piperidin-4-yl]-5-thiophen-2-yl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3SC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN1CCOCC1 JXUXTVXXOBFIHD-UHFFFAOYSA-N 0.000 claims 2
- FPQWIPSAJFRIKL-UHFFFAOYSA-N 3-[1-(3-morpholin-4-ylpropylsulfonyl)piperidin-4-yl]-5-thiophen-3-yl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C3=CSC=C3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN1CCOCC1 FPQWIPSAJFRIKL-UHFFFAOYSA-N 0.000 claims 2
- VQIIDCSRXUTGCN-UHFFFAOYSA-N 3-[1-[3-(diethylamino)propylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCN(CC)CC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 VQIIDCSRXUTGCN-UHFFFAOYSA-N 0.000 claims 2
- GEFQTJSOUFTLDH-SFTDATJTSA-N 3-[1-[3-[(2s,5s)-2,5-dimethylpyrrolidin-1-yl]propylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C[C@H]1CC[C@H](C)N1CCCS(=O)(=O)N1CCC(C=2C3=CC(=CC(=C3NC=2)C(N)=O)C=2C=CC=CC=2)CC1 GEFQTJSOUFTLDH-SFTDATJTSA-N 0.000 claims 2
- YEQAPFBDOIVVRV-UHFFFAOYSA-N 5-phenyl-3-[1-(2-pyrrolidin-1-ylethylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCN1CCCC1 YEQAPFBDOIVVRV-UHFFFAOYSA-N 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 229920006395 saturated elastomer Polymers 0.000 claims 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 2
- JAARXRBVYNQFCZ-UHFFFAOYSA-N 2-tert-butyl-4-(7-carbamoyl-5-thiophen-2-yl-1H-indol-3-yl)piperidine-1-carboxylic acid Chemical compound C1CN(C(O)=O)C(C(C)(C)C)CC1C1=CNC2=C(C(N)=O)C=C(C=3SC=CC=3)C=C12 JAARXRBVYNQFCZ-UHFFFAOYSA-N 0.000 claims 1
- LHEWMBUFYLDXRR-UHFFFAOYSA-N 2-tert-butyl-4-(7-carbamoyl-5-thiophen-3-yl-1H-indol-3-yl)piperidine-1-carboxylic acid Chemical compound C1CN(C(O)=O)C(C(C)(C)C)CC1C1=CNC2=C(C(N)=O)C=C(C3=CSC=C3)C=C12 LHEWMBUFYLDXRR-UHFFFAOYSA-N 0.000 claims 1
- OZMCVPNASJLVTM-UHFFFAOYSA-N 3-(1-ethenylsulfonylpiperidin-4-yl)-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C1CCN(S(=O)(=O)C=C)CC1 OZMCVPNASJLVTM-UHFFFAOYSA-N 0.000 claims 1
- AWEOCCDQVPBWPZ-UHFFFAOYSA-N 3-[1-(2-aminoethylsulfonyl)piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCN)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 AWEOCCDQVPBWPZ-UHFFFAOYSA-N 0.000 claims 1
- FSMXULRZWBGMAR-UHFFFAOYSA-N 3-[1-(2-chloroethylsulfonyl)piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C1CCN(S(=O)(=O)CCCl)CC1 FSMXULRZWBGMAR-UHFFFAOYSA-N 0.000 claims 1
- SVARYXPHSVFBCG-UHFFFAOYSA-N 3-[1-(2-ethoxyethylsulfonyl)piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCOCC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 SVARYXPHSVFBCG-UHFFFAOYSA-N 0.000 claims 1
- ORIMLZAWSAVTJO-UHFFFAOYSA-N 3-[1-(2-hydroxyethylsulfonyl)piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C1CCN(S(=O)(=O)CCO)CC1 ORIMLZAWSAVTJO-UHFFFAOYSA-N 0.000 claims 1
- IBHBSLBQSHEYEW-UHFFFAOYSA-N 3-[1-(2-morpholin-4-ylethylsulfonyl)piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCN1CCOCC1 IBHBSLBQSHEYEW-UHFFFAOYSA-N 0.000 claims 1
- FGZOAPSCWGEAHY-UHFFFAOYSA-N 3-[1-(3-chloropropylsulfonyl)piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C1CCN(S(=O)(=O)CCCCl)CC1 FGZOAPSCWGEAHY-UHFFFAOYSA-N 0.000 claims 1
- XSEDYBNFRPWUPE-UHFFFAOYSA-N 3-[1-(3-chloropropylsulfonyl)piperidin-4-yl]-5-thiophen-2-yl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3SC=CC=3)=CC=2C=1C1CCN(S(=O)(=O)CCCCl)CC1 XSEDYBNFRPWUPE-UHFFFAOYSA-N 0.000 claims 1
- DSRKFMRGYRGPOQ-UHFFFAOYSA-N 3-[1-(3-chloropropylsulfonyl)piperidin-4-yl]-5-thiophen-3-yl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C3=CSC=C3)=CC=2C=1C1CCN(S(=O)(=O)CCCCl)CC1 DSRKFMRGYRGPOQ-UHFFFAOYSA-N 0.000 claims 1
- NHQWNHXUANHIBQ-UHFFFAOYSA-N 3-[1-(3-ethoxypropylsulfonyl)piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOCC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 NHQWNHXUANHIBQ-UHFFFAOYSA-N 0.000 claims 1
- LMUDDZVWGKMCSO-UHFFFAOYSA-N 3-[1-(3-ethoxypropylsulfonyl)piperidin-4-yl]-5-thiophen-2-yl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOCC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3SC=CC=3)C=C12 LMUDDZVWGKMCSO-UHFFFAOYSA-N 0.000 claims 1
- RHWUMIFHSYILHS-UHFFFAOYSA-N 3-[1-(3-hydroxypropylsulfonyl)piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C1CCN(S(=O)(=O)CCCO)CC1 RHWUMIFHSYILHS-UHFFFAOYSA-N 0.000 claims 1
- RNEKLUJSMBDEAU-UHFFFAOYSA-N 3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-5-[3-(methylaminomethyl)phenyl]-1h-indole-7-carboxamide Chemical compound CNCC1=CC=CC(C=2C=C3C(C4CCN(CC4)S(=O)(=O)CCCOC)=CNC3=C(C(N)=O)C=2)=C1 RNEKLUJSMBDEAU-UHFFFAOYSA-N 0.000 claims 1
- QWRVROMFVKSABE-UHFFFAOYSA-N 3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-5-[3-(propylaminomethyl)phenyl]-1h-indole-7-carboxamide Chemical compound CCCNCC1=CC=CC(C=2C=C3C(C4CCN(CC4)S(=O)(=O)CCCOC)=CNC3=C(C(N)=O)C=2)=C1 QWRVROMFVKSABE-UHFFFAOYSA-N 0.000 claims 1
- SFIFIOSFVGXFDX-UHFFFAOYSA-N 3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-5-[3-[(oxolan-2-ylmethylamino)methyl]phenyl]-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=C(CNCC4OCCC4)C=CC=3)C=C12 SFIFIOSFVGXFDX-UHFFFAOYSA-N 0.000 claims 1
- TYCAVTKSGIQXCY-UHFFFAOYSA-N 3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-5-[3-[(pyridin-2-ylmethylamino)methyl]phenyl]-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=C(CNCC=4N=CC=CC=4)C=CC=3)C=C12 TYCAVTKSGIQXCY-UHFFFAOYSA-N 0.000 claims 1
- ZZVICLRBPQIWFL-UHFFFAOYSA-N 3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-5-[3-[(pyridin-4-ylmethylamino)methyl]phenyl]-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=C(CNCC=4C=CN=CC=4)C=CC=3)C=C12 ZZVICLRBPQIWFL-UHFFFAOYSA-N 0.000 claims 1
- RETBTQNBVBDKHK-UHFFFAOYSA-N 3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-5-[3-[[(5-methylfuran-2-yl)methylamino]methyl]phenyl]-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=C(CNCC=4OC(C)=CC=4)C=CC=3)C=C12 RETBTQNBVBDKHK-UHFFFAOYSA-N 0.000 claims 1
- SFIFIOSFVGXFDX-RUZDIDTESA-N 3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-5-[3-[[[(2r)-oxolan-2-yl]methylamino]methyl]phenyl]-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=C(CNC[C@@H]4OCCC4)C=CC=3)C=C12 SFIFIOSFVGXFDX-RUZDIDTESA-N 0.000 claims 1
- RSGCNFUIAYSKBK-NRFANRHFSA-N 3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-5-[3-[[[(2s)-3-methylbutan-2-yl]amino]methyl]phenyl]-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=C(CN[C@@H](C)C(C)C)C=CC=3)C=C12 RSGCNFUIAYSKBK-NRFANRHFSA-N 0.000 claims 1
- CMRSANBYQLHZIF-UHFFFAOYSA-N 3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-5-[3-[[methyl(prop-2-enyl)amino]methyl]phenyl]-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=C(CN(C)CC=C)C=CC=3)C=C12 CMRSANBYQLHZIF-UHFFFAOYSA-N 0.000 claims 1
- JKEGWZMIZMRIBD-UHFFFAOYSA-N 3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-5-thiophen-2-yl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3SC=CC=3)C=C12 JKEGWZMIZMRIBD-UHFFFAOYSA-N 0.000 claims 1
- GMIQJWKIKIPZJZ-UHFFFAOYSA-N 3-[1-(3-morpholin-4-ylpropylsulfonyl)piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN1CCOCC1 GMIQJWKIKIPZJZ-UHFFFAOYSA-N 0.000 claims 1
- JKFFFTQGEYSOEU-UHFFFAOYSA-N 3-[1-(3-pyrrolidin-1-ylpropylsulfonyl)piperidin-4-yl]-5-thiophen-2-yl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3SC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN1CCCC1 JKFFFTQGEYSOEU-UHFFFAOYSA-N 0.000 claims 1
- JUWVRJPAUHWQSQ-UHFFFAOYSA-N 3-[1-[2-(2-hydroxyethylamino)ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C1CCN(S(=O)(=O)CCNCCO)CC1 JUWVRJPAUHWQSQ-UHFFFAOYSA-N 0.000 claims 1
- VYTJESRILHKPAP-UHFFFAOYSA-N 3-[1-[2-(4-acetylpiperazin-1-yl)ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(C(=O)C)CCN1CCS(=O)(=O)N1CCC(C=2C3=CC(=CC(=C3NC=2)C(N)=O)C=2C=CC=CC=2)CC1 VYTJESRILHKPAP-UHFFFAOYSA-N 0.000 claims 1
- RIDOVDOUSMRZLW-UHFFFAOYSA-N 3-[1-[2-(4-hydroxybutoxy)ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C1CCN(S(=O)(=O)CCOCCCCO)CC1 RIDOVDOUSMRZLW-UHFFFAOYSA-N 0.000 claims 1
- KEAKQBUGPVKASK-UHFFFAOYSA-N 3-[1-[2-(4-hydroxypiperidin-1-yl)ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCN1CCC(O)CC1 KEAKQBUGPVKASK-UHFFFAOYSA-N 0.000 claims 1
- ZFDXHNNDKIRZON-UHFFFAOYSA-N 3-[1-[2-(4-hydroxypiperidin-1-yl)ethylsulfonyl]piperidin-4-yl]-5-thiophen-3-yl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C3=CSC=C3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCN1CCC(O)CC1 ZFDXHNNDKIRZON-UHFFFAOYSA-N 0.000 claims 1
- PRVFBTAIXBATKR-UHFFFAOYSA-N 3-[1-[2-(4-methylpiperazin-1-yl)ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(C)CCN1CCS(=O)(=O)N1CCC(C=2C3=CC(=CC(=C3NC=2)C(N)=O)C=2C=CC=CC=2)CC1 PRVFBTAIXBATKR-UHFFFAOYSA-N 0.000 claims 1
- LCCBWWBXSIGSMS-UHFFFAOYSA-N 3-[1-[2-(azepan-1-yl)ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCN1CCCCCC1 LCCBWWBXSIGSMS-UHFFFAOYSA-N 0.000 claims 1
- VDLFSWCPNGKSPJ-UHFFFAOYSA-N 3-[1-[2-(cyclopentylamino)ethylsulfonyl]piperidin-4-yl]-5-thiophen-2-yl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3SC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCNC1CCCC1 VDLFSWCPNGKSPJ-UHFFFAOYSA-N 0.000 claims 1
- WGJGKCAGQVPEGN-UHFFFAOYSA-N 3-[1-[2-(cyclopentylamino)ethylsulfonyl]piperidin-4-yl]-5-thiophen-3-yl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C3=CSC=C3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCNC1CCCC1 WGJGKCAGQVPEGN-UHFFFAOYSA-N 0.000 claims 1
- VTNLMEAPLQOPRY-UHFFFAOYSA-N 3-[1-[2-(diethylamino)ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCN(CC)CC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 VTNLMEAPLQOPRY-UHFFFAOYSA-N 0.000 claims 1
- MJWPHYZQZROWPH-UHFFFAOYSA-N 3-[1-[2-(dimethylamino)ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCN(C)C)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 MJWPHYZQZROWPH-UHFFFAOYSA-N 0.000 claims 1
- LVAVWTZPZUZICV-UHFFFAOYSA-N 3-[1-[2-(dimethylamino)ethylsulfonyl]piperidin-4-yl]-5-thiophen-3-yl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCN(C)C)CCC1C1=CNC2=C(C(N)=O)C=C(C3=CSC=C3)C=C12 LVAVWTZPZUZICV-UHFFFAOYSA-N 0.000 claims 1
- LUYYCKBSMDOEDG-UHFFFAOYSA-N 3-[1-[2-(ethylamino)ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCNCC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 LUYYCKBSMDOEDG-UHFFFAOYSA-N 0.000 claims 1
- VHAKGAMMAGIEMZ-UHFFFAOYSA-N 3-[1-[2-(methylamino)ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCNC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 VHAKGAMMAGIEMZ-UHFFFAOYSA-N 0.000 claims 1
- XWJWBZVRUFRHKL-QFIPXVFZSA-N 3-[1-[2-[(2s)-2-(hydroxymethyl)pyrrolidin-1-yl]ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCN1CCC[C@H]1CO XWJWBZVRUFRHKL-QFIPXVFZSA-N 0.000 claims 1
- TZOXXHAVFRVKIG-DEOSSOPVSA-N 3-[1-[2-[(2s)-2-carbamoylpyrrolidin-1-yl]ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound NC(=O)[C@@H]1CCCN1CCS(=O)(=O)N1CCC(C=2C3=CC(=CC(=C3NC=2)C(N)=O)C=2C=CC=CC=2)CC1 TZOXXHAVFRVKIG-DEOSSOPVSA-N 0.000 claims 1
- LTJSKCCXLGVNJM-UHFFFAOYSA-N 3-[1-[2-[2-(dimethylcarbamoyl)pyrrolidin-1-yl]ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound CN(C)C(=O)C1CCCN1CCS(=O)(=O)N1CCC(C=2C3=CC(=CC(=C3NC=2)C(N)=O)C=2C=CC=CC=2)CC1 LTJSKCCXLGVNJM-UHFFFAOYSA-N 0.000 claims 1
- ZEFMFHWTSYWKAK-UHFFFAOYSA-N 3-[1-[2-[3-(dimethylamino)propyl-methylamino]ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCN(C)CCCN(C)C)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 ZEFMFHWTSYWKAK-UHFFFAOYSA-N 0.000 claims 1
- WQLYHIYMXDUZJF-UHFFFAOYSA-N 3-[1-[2-[4-(2-hydroxyethyl)piperazin-1-yl]ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCN1CCN(CCO)CC1 WQLYHIYMXDUZJF-UHFFFAOYSA-N 0.000 claims 1
- FSZYSJLGKAGYRP-UHFFFAOYSA-N 3-[1-[2-[4-(2-oxo-2-pyrrolidin-1-ylethyl)piperazin-1-yl]ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCN(CC1)CCN1CC(=O)N1CCCC1 FSZYSJLGKAGYRP-UHFFFAOYSA-N 0.000 claims 1
- RHDQGZBTANGHEX-KRWDZBQOSA-N 3-[1-[2-[[(2s)-1-hydroxypropan-2-yl]amino]ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCN[C@H](CO)C)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 RHDQGZBTANGHEX-KRWDZBQOSA-N 0.000 claims 1
- BBMSLOZFILFLPG-KRWDZBQOSA-N 3-[1-[2-[[(2s)-2-hydroxypropyl]amino]ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCNC[C@@H](O)C)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 BBMSLOZFILFLPG-KRWDZBQOSA-N 0.000 claims 1
- LWPHSCRMOFFNKZ-UHFFFAOYSA-N 3-[1-[2-[ethyl(methyl)amino]ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCN(C)CC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 LWPHSCRMOFFNKZ-UHFFFAOYSA-N 0.000 claims 1
- IZSJQTKUDBBFSR-UHFFFAOYSA-N 3-[1-[2-[methyl-[2-(methylamino)ethyl]amino]ethylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCN(C)CCNC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 IZSJQTKUDBBFSR-UHFFFAOYSA-N 0.000 claims 1
- HPDWVZPBSHSNQF-UHFFFAOYSA-N 3-[1-[3-(1-hydroxypropan-2-ylamino)propylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCNC(CO)C)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 HPDWVZPBSHSNQF-UHFFFAOYSA-N 0.000 claims 1
- MORTZTRVMUQYGI-UHFFFAOYSA-N 3-[1-[3-(1-methoxypropan-2-ylamino)propylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCNC(C)COC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 MORTZTRVMUQYGI-UHFFFAOYSA-N 0.000 claims 1
- JRSNJFBHEILWNZ-UHFFFAOYSA-N 3-[1-[3-(2-hydroxybutylamino)propylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCNCC(O)CC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 JRSNJFBHEILWNZ-UHFFFAOYSA-N 0.000 claims 1
- PKCYLBBPQOCAQS-UHFFFAOYSA-N 3-[1-[3-(2-hydroxypropylamino)propylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCNCC(O)C)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 PKCYLBBPQOCAQS-UHFFFAOYSA-N 0.000 claims 1
- VRXVNIYQUOWFOB-UHFFFAOYSA-N 3-[1-[3-(2-methylpyrrolidin-1-yl)propylsulfonyl]piperidin-4-yl]-5-thiophen-2-yl-1h-indole-7-carboxamide Chemical compound CC1CCCN1CCCS(=O)(=O)N1CCC(C=2C3=CC(=CC(=C3NC=2)C(N)=O)C=2SC=CC=2)CC1 VRXVNIYQUOWFOB-UHFFFAOYSA-N 0.000 claims 1
- WGOPFNFAVMYIBW-UHFFFAOYSA-N 3-[1-[3-(3-hydroxypyrrolidin-1-yl)propylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN1CCC(O)C1 WGOPFNFAVMYIBW-UHFFFAOYSA-N 0.000 claims 1
- GPCALZUGZQXFIU-UHFFFAOYSA-N 3-[1-[3-(4-hydroxypiperidin-1-yl)propylsulfonyl]piperidin-4-yl]-5-thiophen-2-yl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3SC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN1CCC(O)CC1 GPCALZUGZQXFIU-UHFFFAOYSA-N 0.000 claims 1
- ZMIODWQUEQJQRY-UHFFFAOYSA-N 3-[1-[3-(4-methylpiperazin-1-yl)propylsulfonyl]piperidin-4-yl]-5-thiophen-2-yl-1h-indole-7-carboxamide Chemical compound C1CN(C)CCN1CCCS(=O)(=O)N1CCC(C=2C3=CC(=CC(=C3NC=2)C(N)=O)C=2SC=CC=2)CC1 ZMIODWQUEQJQRY-UHFFFAOYSA-N 0.000 claims 1
- LBTSTCOTIVCLFQ-UHFFFAOYSA-N 3-[1-[3-(4-methylpiperazin-1-yl)propylsulfonyl]piperidin-4-yl]-5-thiophen-3-yl-1h-indole-7-carboxamide Chemical compound C1CN(C)CCN1CCCS(=O)(=O)N1CCC(C=2C3=CC(=CC(=C3NC=2)C(N)=O)C2=CSC=C2)CC1 LBTSTCOTIVCLFQ-UHFFFAOYSA-N 0.000 claims 1
- RZYUQVVDRRDXNT-UHFFFAOYSA-N 3-[1-[3-(azepan-1-yl)propylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN1CCCCCC1 RZYUQVVDRRDXNT-UHFFFAOYSA-N 0.000 claims 1
- ZUVKDXRTARJACU-UHFFFAOYSA-N 3-[1-[3-(cyclohexylamino)propylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCNC1CCCCC1 ZUVKDXRTARJACU-UHFFFAOYSA-N 0.000 claims 1
- IFOVPMIWVNNDJB-UHFFFAOYSA-N 3-[1-[3-(cyclopentylamino)propylsulfonyl]piperidin-4-yl]-5-thiophen-2-yl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3SC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCNC1CCCC1 IFOVPMIWVNNDJB-UHFFFAOYSA-N 0.000 claims 1
- XOMOJYZAVDKQPK-UHFFFAOYSA-N 3-[1-[3-(dimethylamino)propylsulfonyl]piperidin-4-yl]-5-(1h-pyrazol-4-yl)-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCN(C)C)CCC1C1=CNC2=C(C(N)=O)C=C(C3=CNN=C3)C=C12 XOMOJYZAVDKQPK-UHFFFAOYSA-N 0.000 claims 1
- OWWCZWSAXMTESV-UHFFFAOYSA-N 3-[1-[3-(dimethylamino)propylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCN(C)C)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 OWWCZWSAXMTESV-UHFFFAOYSA-N 0.000 claims 1
- VVRGLRJOJQZVQK-UHFFFAOYSA-N 3-[1-[3-(dimethylamino)propylsulfonyl]piperidin-4-yl]-5-thiophen-2-yl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCN(C)C)CCC1C1=CNC2=C(C(N)=O)C=C(C=3SC=CC=3)C=C12 VVRGLRJOJQZVQK-UHFFFAOYSA-N 0.000 claims 1
- ONGHZGNQHUWTAY-UHFFFAOYSA-N 3-[1-[3-(dimethylamino)propylsulfonyl]piperidin-4-yl]-5-thiophen-3-yl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCN(C)C)CCC1C1=CNC2=C(C(N)=O)C=C(C3=CSC=C3)C=C12 ONGHZGNQHUWTAY-UHFFFAOYSA-N 0.000 claims 1
- KBJCTUCNQIVVEZ-QHCPKHFHSA-N 3-[1-[3-[(2s)-2-(hydroxymethyl)pyrrolidin-1-yl]propylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN1CCC[C@H]1CO KBJCTUCNQIVVEZ-QHCPKHFHSA-N 0.000 claims 1
- VVEGLBSSFBTRMD-UHFFFAOYSA-N 3-[1-[3-[2-(dimethylamino)ethylamino]propylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCNCCN(C)C)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 VVEGLBSSFBTRMD-UHFFFAOYSA-N 0.000 claims 1
- BYMFOMFPRKSKSS-UHFFFAOYSA-N 3-[1-[3-[2-(hydroxymethyl)piperidin-1-yl]propylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN1CCCCC1CO BYMFOMFPRKSKSS-UHFFFAOYSA-N 0.000 claims 1
- KLZUVMOFUKTEHD-UHFFFAOYSA-N 3-[1-[3-[4-[2-oxo-2-(propan-2-ylamino)ethyl]piperazin-1-yl]propylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(CC(=O)NC(C)C)CCN1CCCS(=O)(=O)N1CCC(C=2C3=CC(=CC(=C3NC=2)C(N)=O)C=2C=CC=CC=2)CC1 KLZUVMOFUKTEHD-UHFFFAOYSA-N 0.000 claims 1
- PKCYLBBPQOCAQS-GOSISDBHSA-N 3-[1-[3-[[(2r)-2-hydroxypropyl]amino]propylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCNC[C@H](O)C)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 PKCYLBBPQOCAQS-GOSISDBHSA-N 0.000 claims 1
- MUJZYJFTWFRVDN-QFIPXVFZSA-N 3-[1-[3-[[(2s)-1-hydroxybutan-2-yl]amino]propylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCN[C@H](CO)CC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 MUJZYJFTWFRVDN-QFIPXVFZSA-N 0.000 claims 1
- CJZJGQBLYAHNHA-UHFFFAOYSA-N 3-[1-[3-[[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-methylamino]propylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C=1C=C(O)C=CC=1C(O)CN(C)CCCS(=O)(=O)N(CC1)CCC1C(C1=C2)=CNC1=C(C(N)=O)C=C2C1=CC=CC=C1 CJZJGQBLYAHNHA-UHFFFAOYSA-N 0.000 claims 1
- URKWDRCDAOQQEN-UHFFFAOYSA-N 3-[1-[3-[di(propan-2-yl)amino]propylsulfonyl]piperidin-4-yl]-5-phenyl-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCN(C(C)C)C(C)C)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=CC=CC=3)C=C12 URKWDRCDAOQQEN-UHFFFAOYSA-N 0.000 claims 1
- FNCPPPMDFONPFE-UHFFFAOYSA-N 3-piperidin-4-yl-5-thiophen-2-yl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3SC=CC=3)=CC=2C=1C1CCNCC1 FNCPPPMDFONPFE-UHFFFAOYSA-N 0.000 claims 1
- WTEAZAGTFXNGBW-UHFFFAOYSA-N 3-piperidin-4-yl-5-thiophen-3-yl-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C3=CSC=C3)=CC=2C=1C1CCNCC1 WTEAZAGTFXNGBW-UHFFFAOYSA-N 0.000 claims 1
- PBNMPFZODQRVNT-UHFFFAOYSA-N 5-(3-formylphenyl)-3-[1-(2-methoxyethylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=C(C=O)C=CC=3)C=C12 PBNMPFZODQRVNT-UHFFFAOYSA-N 0.000 claims 1
- YSQWJVBWJPQJPY-UHFFFAOYSA-N 5-(3-formylphenyl)-3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=C(C=O)C=CC=3)C=C12 YSQWJVBWJPQJPY-UHFFFAOYSA-N 0.000 claims 1
- FULAGCPTSQZALE-UHFFFAOYSA-N 5-(4-fluorophenyl)-3-[1-(3-pyrrolidin-1-ylpropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC(F)=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN1CCCC1 FULAGCPTSQZALE-UHFFFAOYSA-N 0.000 claims 1
- YWPJTAUOKIPHEK-UHFFFAOYSA-N 5-(4-methylphenyl)-3-[1-(3-pyrrolidin-1-ylpropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C1=CC(C)=CC=C1C1=CC(C(N)=O)=C(NC=C2C3CCN(CC3)S(=O)(=O)CCCN3CCCC3)C2=C1 YWPJTAUOKIPHEK-UHFFFAOYSA-N 0.000 claims 1
- RQNOFUHMSWQMJM-UHFFFAOYSA-N 5-(5-chlorothiophen-2-yl)-3-[1-(3-pyrrolidin-1-ylpropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3SC(Cl)=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN1CCCC1 RQNOFUHMSWQMJM-UHFFFAOYSA-N 0.000 claims 1
- CBYQDSQGZQSPML-UHFFFAOYSA-N 5-(5-formylthiophen-3-yl)-3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=C(C=O)SC=3)C=C12 CBYQDSQGZQSPML-UHFFFAOYSA-N 0.000 claims 1
- WZZDKHXGPNPARU-UHFFFAOYSA-N 5-[3-(ethylaminomethyl)phenyl]-3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound CCNCC1=CC=CC(C=2C=C3C(C4CCN(CC4)S(=O)(=O)CCCOC)=CNC3=C(C(N)=O)C=2)=C1 WZZDKHXGPNPARU-UHFFFAOYSA-N 0.000 claims 1
- PDGOXJPIYZSOGH-UHFFFAOYSA-N 5-[3-(hydroxymethyl)phenyl]-3-[1-(3-pyrrolidin-1-ylpropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=C(CO)C=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN1CCCC1 PDGOXJPIYZSOGH-UHFFFAOYSA-N 0.000 claims 1
- XDIUYHMEFOQEDV-UHFFFAOYSA-N 5-[3-[(1-methoxypropan-2-ylamino)methyl]phenyl]-3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=C(CNC(C)COC)C=CC=3)C=C12 XDIUYHMEFOQEDV-UHFFFAOYSA-N 0.000 claims 1
- WWFOHLGOAODWDE-UHFFFAOYSA-N 5-[3-[(2,2-dimethylpropylamino)methyl]phenyl]-3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=C(CNCC(C)(C)C)C=CC=3)C=C12 WWFOHLGOAODWDE-UHFFFAOYSA-N 0.000 claims 1
- IJJLIVKMCYRTPB-UHFFFAOYSA-N 5-[3-[(2-ethoxyethylamino)methyl]phenyl]-3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound CCOCCNCC1=CC=CC(C=2C=C3C(C4CCN(CC4)S(=O)(=O)CCCOC)=CNC3=C(C(N)=O)C=2)=C1 IJJLIVKMCYRTPB-UHFFFAOYSA-N 0.000 claims 1
- DIHOWXVDCCQBSI-UHFFFAOYSA-N 5-[3-[(2-methoxyethylamino)methyl]phenyl]-3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=C(CNCCOC)C=CC=3)C=C12 DIHOWXVDCCQBSI-UHFFFAOYSA-N 0.000 claims 1
- WPBSCWQTEGSFRF-UHFFFAOYSA-N 5-[3-[(3-methoxypropylamino)methyl]phenyl]-3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound COCCCNCC1=CC=CC(C=2C=C3C(C4CCN(CC4)S(=O)(=O)CCCOC)=CNC3=C(C(N)=O)C=2)=C1 WPBSCWQTEGSFRF-UHFFFAOYSA-N 0.000 claims 1
- WOJPDCUKFATTGA-UHFFFAOYSA-N 5-[3-[(cyclopropylmethylamino)methyl]phenyl]-3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=C(CNCC4CC4)C=CC=3)C=C12 WOJPDCUKFATTGA-UHFFFAOYSA-N 0.000 claims 1
- YYERDCDGVHQVMR-XMMPIXPASA-N 5-[3-[[(3r)-3-hydroxypyrrolidin-1-yl]methyl]phenyl]-3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=C(CN4C[C@H](O)CC4)C=CC=3)C=C12 YYERDCDGVHQVMR-XMMPIXPASA-N 0.000 claims 1
- JTIVLGNSVMPNJY-NRFANRHFSA-N 5-[3-[[[(2s)-3,3-dimethylbutan-2-yl]amino]methyl]phenyl]-3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(C=3C=C(CN[C@@H](C)C(C)(C)C)C=CC=3)C=C12 JTIVLGNSVMPNJY-NRFANRHFSA-N 0.000 claims 1
- MQJLOOMFYYDRCY-UHFFFAOYSA-N 5-[5-(hydroxymethyl)thiophen-2-yl]-3-[1-(3-pyrrolidin-1-ylpropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3SC(CO)=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN1CCCC1 MQJLOOMFYYDRCY-UHFFFAOYSA-N 0.000 claims 1
- JLCDFUFAQXYXGR-UHFFFAOYSA-N 5-bromo-3-(1-ethenylsulfonylpiperidin-4-yl)-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(Br)=CC=2C=1C1CCN(S(=O)(=O)C=C)CC1 JLCDFUFAQXYXGR-UHFFFAOYSA-N 0.000 claims 1
- DLDFITGBQJJTFD-UHFFFAOYSA-N 5-bromo-3-[1-(2-methoxyethylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCOC)CCC1C1=CNC2=C(C(N)=O)C=C(Br)C=C12 DLDFITGBQJJTFD-UHFFFAOYSA-N 0.000 claims 1
- ZUTPMWWVFOHPDM-UHFFFAOYSA-N 5-bromo-3-[1-(3-chloropropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(Br)=CC=2C=1C1CCN(S(=O)(=O)CCCCl)CC1 ZUTPMWWVFOHPDM-UHFFFAOYSA-N 0.000 claims 1
- PVMQSBIBQIJHPA-UHFFFAOYSA-N 5-bromo-3-[1-(3-methoxypropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C1CN(S(=O)(=O)CCCOC)CCC1C1=CNC2=C(C(N)=O)C=C(Br)C=C12 PVMQSBIBQIJHPA-UHFFFAOYSA-N 0.000 claims 1
- IDCYBVZCFZIBFR-UHFFFAOYSA-N 5-bromo-3-[1-(3-morpholin-4-ylpropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(Br)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN1CCOCC1 IDCYBVZCFZIBFR-UHFFFAOYSA-N 0.000 claims 1
- AJOJYXJQBSYAHU-UHFFFAOYSA-N 5-bromo-3-[1-(3-pyrrolidin-1-ylpropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(Br)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN1CCCC1 AJOJYXJQBSYAHU-UHFFFAOYSA-N 0.000 claims 1
- BNDWZKXEDJIHKQ-UHFFFAOYSA-N 5-phenyl-3-[1-(2-piperidin-1-ylethylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCN1CCCCC1 BNDWZKXEDJIHKQ-UHFFFAOYSA-N 0.000 claims 1
- ROHVMXPLAXOWHS-UHFFFAOYSA-N 5-phenyl-3-[1-(3-pyrrolidin-1-ylpropylsulfonyl)piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN1CCCC1 ROHVMXPLAXOWHS-UHFFFAOYSA-N 0.000 claims 1
- FFARPIKHOHKEMS-UHFFFAOYSA-N 5-phenyl-3-[1-[2-(2-pyrrolidin-1-ylethoxy)ethylsulfonyl]piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCOCCN1CCCC1 FFARPIKHOHKEMS-UHFFFAOYSA-N 0.000 claims 1
- MUYPXSKLACAXLI-UHFFFAOYSA-N 5-phenyl-3-[1-[2-(4-piperidin-1-ylpiperidin-1-yl)ethylsulfonyl]piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCN(CC1)CCC1N1CCCCC1 MUYPXSKLACAXLI-UHFFFAOYSA-N 0.000 claims 1
- MQOUIEQCPDGTEL-UHFFFAOYSA-N 5-phenyl-3-[1-[3-(4-piperidin-1-ylpiperidin-1-yl)propylsulfonyl]piperidin-4-yl]-1h-indole-7-carboxamide Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN(CC1)CCC1N1CCCCC1 MQOUIEQCPDGTEL-UHFFFAOYSA-N 0.000 claims 1
- ZSRPBQJDHXCBGL-RQNOJGIXSA-N C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN[C@H]1CC[C@H](O)CC1 Chemical compound C=1NC=2C(C(=O)N)=CC(C=3C=CC=CC=3)=CC=2C=1C(CC1)CCN1S(=O)(=O)CCCN[C@H]1CC[C@H](O)CC1 ZSRPBQJDHXCBGL-RQNOJGIXSA-N 0.000 claims 1
- 125000005418 aryl aryl group Chemical group 0.000 claims 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61176104P | 2004-09-21 | 2004-09-21 | |
| US69545405P | 2005-06-30 | 2005-06-30 | |
| PCT/US2005/033752 WO2006034317A2 (en) | 2004-09-21 | 2005-09-21 | Chemical compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008513500A JP2008513500A (ja) | 2008-05-01 |
| JP2008513500A5 true JP2008513500A5 (enExample) | 2008-11-06 |
Family
ID=36090636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007532632A Pending JP2008513500A (ja) | 2004-09-21 | 2005-09-21 | 化学物質 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7858796B2 (enExample) |
| EP (1) | EP1793826A4 (enExample) |
| JP (1) | JP2008513500A (enExample) |
| KR (1) | KR20070057969A (enExample) |
| AR (1) | AR054084A1 (enExample) |
| AU (1) | AU2005286795A1 (enExample) |
| BR (1) | BRPI0515524A (enExample) |
| CA (1) | CA2581180A1 (enExample) |
| IL (1) | IL181877A0 (enExample) |
| MA (1) | MA28912B1 (enExample) |
| MX (1) | MX2007003283A (enExample) |
| NO (1) | NO20071988L (enExample) |
| PE (1) | PE20060748A1 (enExample) |
| SG (1) | SG155932A1 (enExample) |
| TW (1) | TW200626142A (enExample) |
| WO (1) | WO2006034317A2 (enExample) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0400895D0 (en) * | 2004-01-15 | 2004-02-18 | Smithkline Beecham Corp | Chemical compounds |
| TW200616967A (en) * | 2004-06-24 | 2006-06-01 | Smithkline Beecham Corp | Novel indazole carboxamides and their use |
| US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
| NZ563687A (en) * | 2005-06-30 | 2011-07-29 | Smithkline Beecham Corp | 3-[1-(ethylsulfonyl)-4-piperidinyl]-5-[2-(1-methylethyl)-2,3-dihydro-1H-isoindol-5-yl]-1H-indole-7-carboxamide for inhibiting IKK2 (aka IKKbeta) |
| JP2009516702A (ja) * | 2005-11-18 | 2009-04-23 | スミスクライン・ビーチャム・コーポレイション | 化合物 |
| EP1959737A4 (en) * | 2005-12-16 | 2010-12-08 | Glaxosmithkline Llc | CHEMICAL COMPOUNDS |
| TWI403320B (zh) * | 2005-12-16 | 2013-08-01 | Infinity Discovery Inc | 用於抑制ｂｃｌ蛋白和結合夥伴間之交互作用的化合物及方法 |
| AR065804A1 (es) * | 2007-03-23 | 2009-07-01 | Smithkline Beecham Corp | Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento |
| ES2443948T3 (es) * | 2008-12-19 | 2014-02-21 | Bristol-Myers Squibb Company | Compuestos de carbazol carboxamida útiles como inhibidores de quinasas |
| EP2370407B1 (en) * | 2008-12-19 | 2014-06-18 | Bristol-Myers Squibb Company | Carbazole and carboline kinase inhibitors |
| US8354539B2 (en) | 2009-03-10 | 2013-01-15 | Glaxo Group Limited | Indole derivatives as IKK2 inhibitors |
| MX2012012966A (es) | 2010-05-07 | 2013-01-22 | Glaxosmithkline Llc | Indoles. |
| US8685969B2 (en) | 2010-06-16 | 2014-04-01 | Bristol-Myers Squibb Company | Carboline carboxamide compounds useful as kinase inhibitors |
| EP3483167A1 (en) * | 2013-06-26 | 2019-05-15 | AbbVie Inc. | Primary carboxamides as btk inhibitors |
| RU2677884C2 (ru) | 2013-09-30 | 2019-01-22 | Гуанчжоу Иннокэа Фарма Тек Ко., Лтд. | Замещенные никотинимидные ингибиторы втк, их получение и применение в терапии раковых, воспалительных и аутоиммунных заболеваний |
| MX393057B (es) | 2014-10-24 | 2025-03-24 | Bristol Myers Squibb Co | Compuestos de indol carboxamida útiles como inhibidores de cinasas. |
| US20170107216A1 (en) | 2015-10-19 | 2017-04-20 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| MD3377488T2 (ro) | 2015-11-19 | 2023-02-28 | Incyte Corp | Compuși heterociclici ca imunomodulatori |
| ES2916874T3 (es) | 2015-12-17 | 2022-07-06 | Incyte Corp | Derivados de N-fenil-piridina-2-carboxamida y su uso como moduladores de la interacción proteína/proteína PD-1/PD-L1 |
| CA3009474A1 (en) | 2015-12-22 | 2017-06-29 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| ES2906460T3 (es) | 2016-05-06 | 2022-04-18 | Incyte Corp | Compuestos heterocíclicos como inmunomoduladores |
| EP3464279B1 (en) | 2016-05-26 | 2021-11-24 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| SG11201811414TA (en) | 2016-06-20 | 2019-01-30 | Incyte Corp | Heterocyclic compounds as immunomodulators |
| MA45669A (fr) | 2016-07-14 | 2019-05-22 | Incyte Corp | Composés hétérocycliques utilisés comme immunomodulateurs |
| US20180057486A1 (en) | 2016-08-29 | 2018-03-01 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| US10308644B2 (en) | 2016-12-22 | 2019-06-04 | Incyte Corporation | Heterocyclic compounds as immunomodulators |
| WO2018119236A1 (en) | 2016-12-22 | 2018-06-28 | Incyte Corporation | Triazolo[1,5-a]pyridine derivatives as immunomodulators |
| WO2018119286A1 (en) | 2016-12-22 | 2018-06-28 | Incyte Corporation | Bicyclic heteroaromatic compounds as immunomodulators |
| WO2018119221A1 (en) | 2016-12-22 | 2018-06-28 | Incyte Corporation | Pyridine derivatives as immunomodulators |
| SMT202300065T1 (it) | 2018-03-30 | 2023-05-12 | Incyte Corp | Composti eterociclici come immunomodulatori |
| CN112752756B (zh) | 2018-05-11 | 2024-06-25 | 因赛特公司 | 作为PD-L1免疫调节剂的四氢-咪唑并[4,5-c]吡啶衍生物 |
| TW202115059A (zh) | 2019-08-09 | 2021-04-16 | 美商英塞特公司 | Ｐｄ—１／ｐｄ—ｌ１抑制劑之鹽 |
| JP7559059B2 (ja) | 2019-09-30 | 2024-10-01 | インサイト・コーポレイション | 免疫調節剤としてのピリド［３，２－ｄ］ピリミジン化合物 |
| EP4058461A1 (en) | 2019-11-11 | 2022-09-21 | Incyte Corporation | Salts and crystalline forms of a pd-1/pd-l1 inhibitor |
| US11780836B2 (en) | 2020-11-06 | 2023-10-10 | Incyte Corporation | Process of preparing a PD-1/PD-L1 inhibitor |
| US11760756B2 (en) | 2020-11-06 | 2023-09-19 | Incyte Corporation | Crystalline form of a PD-1/PD-L1 inhibitor |
| IL302590A (en) | 2020-11-06 | 2023-07-01 | Incyte Corp | Process for preparing PD-1/PD-L1 inhibitor and salts and crystalline forms thereof |
Family Cites Families (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4775761A (en) * | 1983-08-22 | 1988-10-04 | Hoechst-Roussel Pharmaceuticals, Inc. | 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles |
| DE3342632A1 (de) | 1983-11-25 | 1985-06-05 | Merck Patent Gmbh, 6100 Darmstadt | Indolderivate |
| US5256673A (en) * | 1983-11-25 | 1993-10-26 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Indole-3-yl-A-tetrahydropyridyl or piperidyl compounds |
| ES2059408T3 (es) | 1987-02-10 | 1994-11-16 | Abbott Lab | Un proceso para la preparacion de un compuesto. |
| IL95584A (en) | 1989-09-07 | 1995-03-15 | Abbott Lab | Indole-, benzoporene- and benzothiophene compounds including lipoxygenase-inhibiting compounds and pharmaceutical compounds containing them |
| US5330986A (en) * | 1992-11-24 | 1994-07-19 | Hoechst-Roussel Pharmaceuticals Inc. | Indole-7-carboxamide derivatives |
| FR2701026B1 (fr) | 1993-02-02 | 1995-03-31 | Adir | Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
| DE19500689A1 (de) | 1995-01-12 | 1996-07-18 | Merck Patent Gmbh | Indolpiperidin-Derivate |
| US5846982A (en) | 1996-06-14 | 1998-12-08 | Eli Lilly And Company | Inhibition of serotonin reuptake |
| EP1077213A3 (en) | 1996-06-14 | 2001-06-13 | Eli Lilly And Company | Inhibition of serotonin reuptake |
| AR013669A1 (es) | 1997-10-07 | 2001-01-10 | Smithkline Beecham Corp | Compuestos y metodos |
| DE19807993A1 (de) | 1998-02-26 | 1999-09-02 | Bayer Ag | Verwendung von ß-Carbolinderivaten zur Bekämpfung von TNF-alpha-abhängigen Krankheiten |
| NZ510588A (en) * | 1998-09-18 | 2003-08-29 | Abbott Gmbh & Co | Pyrrolopyrimidines as protein kinase inhibitors |
| DE19928424A1 (de) | 1999-06-23 | 2000-12-28 | Aventis Pharma Gmbh | Substituierte Benzimidazole |
| DE19951360A1 (de) | 1999-10-26 | 2001-05-03 | Aventis Pharma Gmbh | Substituierte Indole |
| MXPA02004555A (es) | 1999-11-08 | 2004-09-10 | Wyeth Corp | Azetidinas de [(indol-??3-il)cicloalquil]-3-substituidas para el tratamiento de padecimientos del sistema nervioso central. |
| US6245799B1 (en) * | 1999-11-08 | 2001-06-12 | American Home Products Corp | [(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders |
| GB0003154D0 (en) | 2000-02-12 | 2000-04-05 | Astrazeneca Uk Ltd | Novel compounds |
| EP1209158A1 (en) | 2000-11-18 | 2002-05-29 | Aventis Pharma Deutschland GmbH | Substituted beta-carbolines |
| EP1134221A1 (en) | 2000-03-15 | 2001-09-19 | Aventis Pharma Deutschland GmbH | Substituted beta-carbolines as lkB kinase inhibitors |
| EP1268477B1 (en) | 2000-03-15 | 2010-04-21 | Sanofi-Aventis Deutschland GmbH | Substituted beta-carbolines with ikb-kinase inhibiting activity |
| TWI310035B (en) | 2000-04-28 | 2009-05-21 | Acadia Pharm Inc | Muscarinic agonists |
| EP1293206A4 (en) | 2000-05-15 | 2005-09-21 | Kissei Pharmaceutical | LIQUID PREPARATION BASED ON WATER |
| US6414013B1 (en) | 2000-06-19 | 2002-07-02 | Pharmacia & Upjohn S.P.A. | Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention |
| HK1052705B (en) | 2000-08-14 | 2006-09-29 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted pyrazole |
| AU2001279958A1 (en) | 2000-08-17 | 2002-03-04 | Celltech R And D Limited | Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatorydisorders |
| CN1642973A (zh) * | 2000-09-06 | 2005-07-20 | 奥索-麦克尼尔药品公司 | 治疗变态反应的方法 |
| JP4272338B2 (ja) | 2000-09-22 | 2009-06-03 | バイエル アクチェンゲゼルシャフト | ピリジン誘導体 |
| AU1182702A (en) | 2000-10-03 | 2002-04-15 | Bristol Myers Squibb Co | Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| US6869956B2 (en) * | 2000-10-03 | 2005-03-22 | Bristol-Myers Squibb Company | Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK) |
| AU2002211663A1 (en) | 2000-10-12 | 2002-04-22 | Smith Kline Beecham Corporation | Nf-$g(k)b inhibitors |
| EP1328272A1 (en) | 2000-10-12 | 2003-07-23 | SmithKline Beecham Corporation | Nf-kappa-b inhibitors |
| CN1503673A (zh) | 2000-10-26 | 2004-06-09 | �㽭�пؼ����ɷ�����˾ | 消炎药 |
| JP2002193938A (ja) | 2000-12-01 | 2002-07-10 | Bayer Ag | ４−アリールピリジン誘導体 |
| US7122544B2 (en) | 2000-12-06 | 2006-10-17 | Signal Pharmaceuticals, Llc | Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto |
| EA200300717A1 (ru) | 2000-12-22 | 2003-12-25 | Уайт | Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов |
| CZ20032287A3 (cs) | 2001-02-01 | 2004-02-18 | Bristol-Myers Squibb Company | Způsoby léčení zánětlivých a imunitních nemocí za použití inhibitorů IkB kinázy (IKK) |
| DE10112151A1 (de) | 2001-03-14 | 2002-09-19 | Merck Patent Gmbh | Substituierte Benzofuran-2-carbonsäureamide |
| WO2002094265A1 (en) | 2001-05-24 | 2002-11-28 | Leo Pharma A/S | A method of modulating nf-$g(k)b activity |
| US7304066B2 (en) | 2001-05-24 | 2007-12-04 | Bjoerkling Fredrik | Pyridyl cyanoguanidine compounds |
| US20030045515A1 (en) | 2001-05-24 | 2003-03-06 | Lise Binderup | Combination medicament for treatment of neoplastic diseases |
| SE0102616D0 (sv) | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
| SE0102617D0 (sv) | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
| US20030127204A1 (en) | 2001-09-06 | 2003-07-10 | Varnell Daniel F. | Amphoteric polymer resins that increase the rate of sizing development |
| US20030109550A1 (en) * | 2001-09-19 | 2003-06-12 | Michael Clare | Substituted indazole compounds for the treatment of inflammation |
| EP1444207A2 (en) | 2001-09-19 | 2004-08-11 | Pharmacia Corporation | Substituted pyrazolyl-compounds for the treatment of inflammation |
| CA2460939C (en) | 2001-09-19 | 2008-07-29 | Pharmacia Corporation | Substituted pyrazolyl compounds for the treatment of inflammation |
| JP2005507892A (ja) | 2001-09-19 | 2005-03-24 | ファルマシア・コーポレーション | 炎症の治療のための置換されたピラゾリルベンゼンスルファミド化合物 |
| AU2002356871A1 (en) | 2001-10-30 | 2003-05-12 | Pharmacia Corporation | Heteroaromatic carboxamide derivatives for the treatment of inflammation |
| CA2476665A1 (en) | 2002-02-19 | 2003-08-28 | Pharmacia Corporation | Tricyclic pyrazole derivatives for the treatment of inflammation |
| AU2003222106A1 (en) | 2002-04-03 | 2003-10-20 | Bristol-Myers Squibb Company | Thiopene-based tricyclic compounds and pharmaceutical compositions comprising same |
| EP1501805A1 (en) | 2002-05-09 | 2005-02-02 | Pharmacia Corporation | Substituted pyrazolyl compounds for the treatment of inflammation |
| BR0311605A (pt) | 2002-06-06 | 2005-02-22 | Boehringer Ingelheim Pharma | Compostos de amida de ácido 3-aminotieno[2,3-b]piridina-2-carboxìlico substituìdo e processos para preparação e seus usos |
| US6900206B2 (en) * | 2002-06-20 | 2005-05-31 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
| DE10237722A1 (de) | 2002-08-17 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase |
| NZ538932A (en) | 2002-08-29 | 2007-04-27 | Boehringer Ingelheim Pharma | 3-(sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative disease |
| SE0202693D0 (sv) * | 2002-09-11 | 2002-09-11 | Astrazeneca Ab | Compounds |
| US6911445B2 (en) | 2002-09-12 | 2005-06-28 | Wyeth | Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans |
| US6919334B2 (en) | 2002-09-12 | 2005-07-19 | Wyeth | Antidepressant azaheterocyclymethyl derivatives of 4,5-dihydroimidazo[1,4,5-de][1,4]benzoxazine |
| US7135479B2 (en) | 2002-09-12 | 2006-11-14 | Wyeth | Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans |
| DE10259244A1 (de) | 2002-12-17 | 2004-07-01 | Merck Patent Gmbh | N-(Indolethyl-)cycloamin-Verbindungen |
| US7329668B2 (en) | 2003-02-25 | 2008-02-12 | Bristol-Myers Squibb Company | Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| GB0308466D0 (en) | 2003-04-11 | 2003-05-21 | Novartis Ag | Organic compounds |
| US7176214B2 (en) | 2003-05-21 | 2007-02-13 | Bristol-Myers Squibb Company | Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| JP2007533602A (ja) | 2003-07-31 | 2007-11-22 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 置換ベンゾチオフェン化合物及びそれらの使用 |
| US7291733B2 (en) | 2003-10-10 | 2007-11-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted tricyclic heterocycles and their uses |
| GB0400895D0 (en) * | 2004-01-15 | 2004-02-18 | Smithkline Beecham Corp | Chemical compounds |
| TW200616967A (en) * | 2004-06-24 | 2006-06-01 | Smithkline Beecham Corp | Novel indazole carboxamides and their use |
| NZ563687A (en) | 2005-06-30 | 2011-07-29 | Smithkline Beecham Corp | 3-[1-(ethylsulfonyl)-4-piperidinyl]-5-[2-(1-methylethyl)-2,3-dihydro-1H-isoindol-5-yl]-1H-indole-7-carboxamide for inhibiting IKK2 (aka IKKbeta) |
-
2005
- 2005-09-19 TW TW094132222A patent/TW200626142A/zh unknown
- 2005-09-19 PE PE2005001077A patent/PE20060748A1/es not_active Application Discontinuation
- 2005-09-20 AR ARP050103900A patent/AR054084A1/es unknown
- 2005-09-21 CA CA002581180A patent/CA2581180A1/en not_active Abandoned
- 2005-09-21 WO PCT/US2005/033752 patent/WO2006034317A2/en not_active Ceased
- 2005-09-21 JP JP2007532632A patent/JP2008513500A/ja active Pending
- 2005-09-21 US US11/575,416 patent/US7858796B2/en not_active Expired - Fee Related
- 2005-09-21 BR BRPI0515524-0A patent/BRPI0515524A/pt not_active IP Right Cessation
- 2005-09-21 AU AU2005286795A patent/AU2005286795A1/en not_active Abandoned
- 2005-09-21 MX MX2007003283A patent/MX2007003283A/es unknown
- 2005-09-21 SG SG200906215-9A patent/SG155932A1/en unknown
- 2005-09-21 KR KR1020077009055A patent/KR20070057969A/ko not_active Withdrawn
- 2005-09-21 EP EP05798511A patent/EP1793826A4/en not_active Withdrawn
-
2007
- 2007-03-12 IL IL181877A patent/IL181877A0/en unknown
- 2007-03-29 MA MA29785A patent/MA28912B1/fr unknown
- 2007-04-18 NO NO20071988A patent/NO20071988L/no not_active Application Discontinuation